Pfizer puts 74 Swiss jobs on chopping block as it folds Seagen into its cancer operations

After telegraphing more than a hundred potential layoffs in March in connection with plans to stop construction of a massive Seagen facility, Pfizer is plowing ahead with efforts to streamline its newly combined cancer business.